Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Senate
Fierce Pharma
Senate revives Orphan Cures Act in Trump's tax bill
The Senate's updated "big, beautiful bill" would allow drugs with multiple rare disease indications to be exempt from Medicare price negotiations.
Angus Liu
Jun 30, 2025 10:09am
Senators grill NIH chief over proposed $18B cut
Jun 10, 2025 5:21pm
Senators call for probe into neural data collection and security
Apr 28, 2025 3:00pm
Senate confirms Trump’s pick as NIH director
Mar 26, 2025 10:01am
Trump's NIH nominee says he doesn't intend to cut more workers
Mar 5, 2025 4:00pm
VC firms, biotechs push back on drug pricing reforms
Jul 25, 2022 11:07am
